These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 963916)

  • 1. Inhibition of the enzymatic activity of the first component of complement (C1) by heparin.
    Strunk R; Colten HR
    Clin Immunol Immunopathol; 1976 Sep; 6(2):248-55. PubMed ID: 963916
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.
    Donaldson VH; Rosen FS; Bing DH
    Trans Assoc Am Physicians; 1977; 90():174-83. PubMed ID: 148134
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides.
    Nagaki K; Inai S
    Int Arch Allergy Appl Immunol; 1976; 50(2):172-80. PubMed ID: 128530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement.
    Pitts JS; Donaldson VH; Forristal J; Wyatt RJ
    J Lab Clin Med; 1978 Oct; 92(4):501-7. PubMed ID: 712189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary angio-oedema: its pathogenesis and management.
    Ballogh Z; Whaley K
    Scott Med J; 1980 Jul; 25(3):187-95. PubMed ID: 7444430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions.
    Loos M; Volanakis JE; Stroud RM
    Immunochemistry; 1976 Sep; 13(9):789-91. PubMed ID: 992701
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4.
    Raepple E; Hill HU; Loos M
    Immunochemistry; 1976 Mar; 13(3):251-5. PubMed ID: 1278930
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of aspirin on complement in vivo.
    Voigtländer V; Hänsch GM; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):145-9. PubMed ID: 7351346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteolytic activation systems of complement.
    Reid KB; Porter RR
    Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of hereditary angioneurotic edema.
    Donaldson VH
    N Engl J Med; 1983 May; 308(18):1094-5. PubMed ID: 6601241
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1977 Nov; 119(5):1690-9. PubMed ID: 410881
    [No Abstract]   [Full Text] [Related]  

  • 15. Function of the activated fourth component of complement (C4b) in activation of C2.
    Vogt W; Hinsch B; Schmidt G; von Zabern I
    FEBS Lett; 1982 Aug; 144(2):195-8. PubMed ID: 6981526
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.
    Donaldson VH; Rosen FS; Bing DH
    Adv Exp Med Biol; 1983; 156():183-91. PubMed ID: 6222633
    [No Abstract]   [Full Text] [Related]  

  • 17. Genius at work: Osler's 1888 article on hereditary angioedema.
    deShazo RD; Frank MM
    Am J Med Sci; 2010 Feb; 339(2):179-81. PubMed ID: 20145435
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual function of insoluble polyanions. Formation of C1 and C42 sites in addition to activation of the alternative pathway of complement.
    Burger R; Loos M; Kossorotow A; Hadding U; Bitter-Suermann D
    Monogr Allergy; 1977; 12():78-81. PubMed ID: 917023
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V; Beuscher HU
    Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement components in hereditary angioedema and chronic urticaria.
    Laurell AB; Mårtensson U; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1975; 49(1-2):86-8. PubMed ID: 124709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.